Related Experiment Video
Updated: Mar 13, 2026
05:50
Two Different Real-Time Place Preference Paradigms Using Optogenetics within the Ventral Tegmental Area of the Mouse
Published on: February 12, 2020
14.7K
From the Uppsala Monitoring Centre : A Review of Viewpoint Part 1 and Part 2
1Uppsala Monitoring Centre, Stora Torget 3, 753 20, Uppsala, Sweden.
Drug Safety
|October 11, 2016
Summary
The Uppsala Monitoring Centre collects adverse drug reaction reports to identify drug hazards. Their publication, Viewpoint, offers accessible pharmacovigilance information to enhance patient safety globally.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Public Health
Background:
- The Uppsala Monitoring Centre (UMC) is central to the WHO Programme for International Drug Monitoring.
- Collecting and processing adverse drug reaction (ADR) reports is a key function.
- Communicating drug safety information to diverse audiences is a high priority.
Purpose of the Study:
- To detail the UMC's role in global pharmacovigilance.
- To highlight the importance of early detection of potential drug hazards.
- To introduce the Viewpoint publication as an accessible resource for drug safety information.
Main Methods:
- Collection and processing of adverse drug reaction reports from WHO Programme member countries.
- Dissemination of drug safety information to professional and general audiences.
- Publication of the 'Viewpoint' series.
Main Results:
- Established a system for detecting early signals of potential drug hazards.
- Facilitated communication of drug safety issues to a wide audience.
- Launched 'Viewpoint' as a pioneering resource for international pharmacovigilance.
Conclusions:
- The UMC plays a vital role in global drug safety surveillance.
- Accessible information on pharmacovigilance is crucial for improving patient safety.
- 'Viewpoint' serves as a valuable tool for both specialists and the general public.
